Clinical Edge Journal Scan

Survival correlates with response to preoperative chemotherapy in CRPM patients undergoing CRS/HIPEC


 

Key clinical point: In patients with colorectal peritoneal metastasis (CRPM), survival is closely related to pathological response (PR) ratio to preoperative chemotherapy in patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), with best outcomes observed in patients with complete PR (CPR).

Major finding: The rate of complications was significantly higher in the low PR (LPR; 65.2%) vsvs CPR (55%) and high PR (HPR; 42.8%; P = .03) groups. Disease-free survival was significantly higher in CPR and HPR vsvs LPR groups ( P less than .001). Overall survival was significantly higher in CPR vsvs HPR and LPR groups ( P = .004).

Study details: Findings are from a retrospective analysis of 178 patients with CRPM who underwent a CRS/HIPEC procedure and had a final completeness of cytoreduction score of 0. Based on the ratio of tumor-positive specimens to the total number of specimens resected, patients were categorized into CPR, HPR, and LPR groups.

Disclosures: The authors did not declare any source of funding. All the authors declared no conflicts of interest.

Source: Mor E et al. Ann Surg Oncol. 2021 Jul 7. doi: 10.1245/s10434-021-10367-6 .

Recommended Reading

Chemotherapy/local excision avoids proctectomy in rectal cancer
MDedge Hematology and Oncology
CRC screening guidelines: 45 is the new 50, and 85 is the new 75
MDedge Hematology and Oncology
NPs and PAs performing colonoscopies: Why not?
MDedge Hematology and Oncology
Performance matters in adenoma detection
MDedge Hematology and Oncology
Early-onset CRC associated with longer survival
MDedge Hematology and Oncology
Antibiotic linked to rise in early onset colon cancer?
MDedge Hematology and Oncology
Mutational signature may reveal underlying link between red meat and CRC
MDedge Hematology and Oncology
Good survival, outcomes with TARE for HCC in practice
MDedge Hematology and Oncology
Higher preoperative dietary fiber intake may reduce complications after CRC surgery
MDedge Hematology and Oncology
No benefit of adding pembrolizumab to neoadjuvant chemoradiotherapy in LARC
MDedge Hematology and Oncology